World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
43
Citations
8259
World Ranking
2968
National Ranking
1410

Veronica Galvan publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Veronica Galvan sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 78 publications — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Veronica Galvan D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Veronica Galvan sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 43 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Veronica Galvan is affiliated with the University of Oklahoma Health Sciences Center in the United States. Their research spans several fields, primarily focusing on medicine, biochemistry, genetics and molecular biology, and neuroscience. They have published extensively in subfields such as neurology, physiology, molecular biology, infectious diseases, and aging.

The main topics of their work include Alzheimer's disease research and treatments, neuroinflammation and neurodegeneration mechanisms, neurological disease mechanisms and treatments, telomeres, telomerase and senescence, genetics, aging and longevity in model organisms, as well as SARS-CoV-2 and COVID-19 research, including clinical studies.

Recent papers by Veronica Galvan illustrate the scope of their research interests. These include:

  • "Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer's disease-like neuroinflammation and cognitive impairment," published in 2021 in Molecular Neurodegeneration
  • "Monkeypox: considerations for the understanding and containment of the current outbreak in non-endemic countries," from 2022 in GeroScience
  • "Omicron variant of the SARS-CoV-2: a quest to define the consequences of its high mutational load," published in 2021 in GeroScience
  • "Soluble pathogenic tau enters brain vascular endothelial cells and drives cellular senescence and brain microvascular dysfunction in a mouse model of tauopathy," from 2023 in Nature Communications
  • "In Vivo Generation of Lung and Thyroid Tissues from Embryonic Stem Cells Using Blastocyst Complementation," published in 2020 in American Journal of Respiratory and Critical Care Medicine

Frequent co-authors in their research collaborations include Stacy A. Hussong, Candice E. Van Skike, Jorge Quarleri, Angela O. Dorigatti, and Zoltán Ungvári. These collaborations reflect sustained partnerships with experts contributing to overlapping research areas.

Veronica Galvan has published notably in several journals, with the highest number of publications appearing in GeroScience, followed by Alzheimer's & Dementia, bioRxiv (Cold Spring Harbor Laboratory), Molecular Neurodegeneration, and Nature Communications.

Best Publications

  • Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease

    Patricia Spilman;Natalia Podlutskaya;Matthew J. Hart;Jayanta Debnath

  • Mechanisms of Vascular Aging

    Zoltan Ungvari;Stefano Tarantini;Anthony J. Donato;Anthony J. Donato;Veronica Galvan

  • Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw,Ind) mice.

    Kunlin Jin;Veronica Galvan;Lin Xie;Xiao Ou Mao

  • Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner

    Veronica Galvan;Bernard Roizman

  • Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664

    Veronica Galvan;Olivia F. Gorostiza;Surita Banwait;Marina Ataie

  • In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid β-peptide of APP

    D. Allan Butterfield;Veronica Galvan;Miranda Bader Lange;Huidong Tang

  • Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice.

    Jonathan Halloran;Stacy Hussong;Raquel Burbank;Natalia Podlutskaya

  • Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease.

    Ai Ling Lin;Wei Zheng;Jonathan J. Halloran;Raquel R. Burbank

  • Transplantation of human neural precursor cells in Matrigel scaffolding improves outcome from focal cerebral ischemia after delayed postischemic treatment in rats.

    Kunlin Jin;XiaoOu Mao;Lin Xie;Veronica Galvan

  • Glycoprotein D or J delivered in trans blocks apoptosis in SK-N-SH cells induced by a herpes simplex virus 1 mutant lacking intact genes expressing both glycoproteins.

    Guoying Zhou;Veronica Galvan;Gabriella Campadelli-Fiume;Bernard Roizman

  • Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer's disease

    Juan Beauquis;Patricio Pavía;Carlos Pomilio;Angeles Vinuesa

  • Rapamycin and Alzheimer's disease: Time for a clinical trial?

    Matt Kaeberlein;Veronica Galvan;Veronica Galvan

  • Aβ induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597–624)

    G. M. Shaked;M. P. Kummer;D. C. Lu;V. Galvan

  • Deficits in Synaptic Transmission and Learning in Amyloid Precursor Protein (APP) Transgenic Mice Require C-Terminal Cleavage of APP

    Michael J. Saganich;Brock E. Schroeder;Veronica Galvan;Dale E. Bredesen

  • Polyphosphate: A Conserved Modifier of Amyloidogenic Processes

    Claudia M. Cremers;Daniela Knoefler;Stephanie Gates;Nicholas Martin

  • Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer's disease.

    Ai Ling Lin;Jordan B. Jahrling;Wei Zhang;Nicholas Derosa

  • Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain

    D. L. Vogt;D. Thomas;V. Galvan;D. E. Bredesen

  • Neurogenesis in the aging brain.

    Veronica Galvan;Kunlin Jin

  • Netrin-1 interacts with amyloid precursor protein and regulates amyloid-|[beta]| production

    F C Lourenço;V Galvan;J Fombonne;V Corset

  • How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story.

    Arlan Richardson;Veronica Galvan;Ai Ling Lin;Salvatore Oddo

Frequent Co-Authors

Dale E. Bredesen
Dale E. Bredesen University of California, Los Angeles
Arlan Richardson
Arlan Richardson University of Oklahoma Health Sciences Center
Kunlin Jin
Kunlin Jin University of North Texas Health Science Center
Salvatore Oddo
Salvatore Oddo Arizona State University
Zoltan Ungvari
Zoltan Ungvari University of Oklahoma Health Sciences Center
Anna Csiszar
Anna Csiszar University of Oklahoma Health Sciences Center
David A. Greenberg
David A. Greenberg Buck Institute for Research on Aging
Martin A. Javors
Martin A. Javors The University of Texas Health Science Center at San Antonio
Goutam Ghosh Choudhury
Goutam Ghosh Choudhury The University of Texas Health Science Center at San Antonio
Bernard Roizman
Bernard Roizman University of Chicago

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Molecular Biology can open the door to a range of related career pathways and online degree programs. Many students interested in science or healthcare fields consider expanding their qualifications with specialized online degrees. For those looking for affordability, you might explore most affordable online master's in education, which can add teaching credentials or broaden your skill set for science communication roles.

If you are fascinated by scientific information management, check out colleges with library science programs. This pathway is ideal for careers in research, archiving, or scientific resource management.

Molecular Biology graduates may also consider healthcare-related paths. For example, pursuing asha accredited slp programs can prepare you for roles in clinical practice or healthcare research. If your undergraduate background is not in SLP, explore the SLP bridge pathway for communication sciences graduates to transition smoothly into this field.

Each of these options provides unique ways to leverage your background in Molecular Biology for a broader array of scientific and professional careers.

Best Scientists Citing Veronica Galvan

Trending Scientists